News

A protein found in extracellular vesicles shed by tumor cells could be used as a liquid biopsy biomarker to better predict the success of immunotherapy for lung cancer patients.

Measuring circulating tumor DNA following surgery to treat colon cancer can predict the risk of cancer recurrence and help direct the use of chemotherapy.

A team of international researchers has demonstrated that blocking adenosine A2B receptors reactivates the immune system in the tumor microenvironment and demonstrates its effectiveness in cancer immunotherapy.

Researchers have developed a way to attack synovial sarcoma, a rare tumor of soft tissues, using an investigational drug that triggers cell death.

Researchers use lab-grown mini liver tumors co-cultured with endothelial cells, revealing chemokine signaling by these cells that drive liver cancer progression and poor survival in patients.

A study of 1.3 million women has indicated that increasing the cervical screening interval from three to five years is safe for people aged 24–49, following a negative HPV test.

A team of researchers has identified the molecular and cellular mechanisms that regulate selective autophagy in the fruit fly Drosophila melanogaster.

High levels of a unique immune cell type are associated with an increased chance of remaining cancer-free after surgery for patients with non-small-cell lung cancer.

Breast cancer and diabetes are both common diseases, with past epidemiological data suggesting the two are linked. A new study has identified a mechanism by which breast cancer cells could impair the function of pancreatic islet cells.

Researchers have developed a cancer immunotherapy platform that is guided by ultrasound, generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade.